These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 32422899)

  • 1. Synergistic Effects of Thiosemicarbazides with Clinical Drugs against
    Chudzik-Rząd B; Malm A; Trotsko N; Wujec M; Plech T; Paneth A
    Molecules; 2020 May; 25(10):. PubMed ID: 32422899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
    Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerases inhibitors.
    Paneth A; Stączek P; Plech T; Strzelczyk A; Dzitko K; Wujec M; Kuśmierz E; Kosikowska U; Grzegorczyk A; Paneth P
    J Enzyme Inhib Med Chem; 2016; 31(1):14-22. PubMed ID: 25792505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiosemicarbazide Derivatives Decrease the ATPase Activity of
    Kowalczyk A; Paneth A; Trojanowski D; Paneth P; Zakrzewska-Czerwińska J; Stączek P
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomyelitis-relevant antibiotics at clinical concentrations show limited effectivity against acute and chronic intracellular
    Zelmer AR; Yang D; Gunn NJ; Solomon LB; Nelson R; Kidd SP; Richter K; Atkins GJ
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0080824. PubMed ID: 39194210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides.
    Siwek A; Stączek P; Stefańska J
    Eur J Med Chem; 2011 Nov; 46(11):5717-26. PubMed ID: 21978836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of microbiologically active thiosemicarbazides derived from hydroxybenzoic acid hydrazides.
    Plech T; Paneth A; Kaproń B; Kosikowska U; Malm A; Strzelczyk A; Stączek P
    Chem Biol Drug Des; 2015 Mar; 85(3):315-25. PubMed ID: 25043121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
    Zinner SH; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2018 Dec; 52(6):854-860. PubMed ID: 30236953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
    Alt S; Mitchenall LA; Maxwell A; Heide L
    J Antimicrob Chemother; 2011 Sep; 66(9):2061-9. PubMed ID: 21693461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility profile and synergistic effect of non-steroidal anti-inflammatory drugs on antibacterial activity of resistant antibiotics (Oxytetracycline and Gentamicin) against methicillin resistant Staphylococcus aureus (MRSA).
    Altaf M; Ijaz M; Ghaffar A; Rehman A; Avais M
    Microb Pathog; 2019 Dec; 137():103755. PubMed ID: 31542423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and docking studies of topoisomerase IV inhibition by thiosemicarbazides.
    Siwek A; Stączek P; Wujec M; Stefańska J; Kosikowska U; Malm A; Jankowski S; Paneth P
    J Mol Model; 2011 Sep; 17(9):2297-303. PubMed ID: 21080016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics.
    Nair S; Desai S; Poonacha N; Vipra A; Sharma U
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7280-7289. PubMed ID: 27671070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, gentamicin and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility.
    Suchý T; Šupová M; Sauerová P; Hubálek Kalbáčová M; Klapková E; Pokorný M; Horný L; Závora J; Ballay R; Denk F; Sojka M; Vištejnová L
    Eur J Pharm Biopharm; 2019 Jul; 140():50-59. PubMed ID: 31055065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
    Tsuji BT; Rybak MJ
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring synergistic and antagonistic interactions in phage-antibiotic combinations against ESKAPE pathogens.
    Kunz Coyne AJ; Eshaya M; Bleick C; Vader S; Biswas B; Wilson M; Deschenes MV; Alexander J; Lehman SM; Rybak MJ
    Microbiol Spectr; 2024 Oct; 12(10):e0042724. PubMed ID: 39082827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Activity of Lupinifolin in Combinations with Antibiotics Against
    Rattanakiat S; Kaewchang K; Thongsang S; Jaruchotikamol A; Pulbutr P
    Pak J Biol Sci; 2021 Jan; 24(6):656-662. PubMed ID: 34486341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.